393 related articles for article (PubMed ID: 32396858)
1. The Glioma Stem Cell Model in the Era of Single-Cell Genomics.
Suvà ML; Tirosh I
Cancer Cell; 2020 May; 37(5):630-636. PubMed ID: 32396858
[TBL] [Abstract][Full Text] [Related]
2. Functional Roles of Long Non-Coding RNAs (LncRNAs) in Glioma Stem Cells.
Wang L; He Z
Med Sci Monit; 2019 Oct; 25():7567-7573. PubMed ID: 31593561
[TBL] [Abstract][Full Text] [Related]
3. NT5DC2 promotes tumorigenicity of glioma stem-like cells by upregulating fyn.
Guo S; Ran H; Xiao D; Huang H; Mi L; Wang X; Chen L; Li D; Zhang S; Han Q; Zhou T; Li A; Man J
Cancer Lett; 2019 Jul; 454():98-107. PubMed ID: 30978441
[TBL] [Abstract][Full Text] [Related]
4. NFAT1-Mediated Regulation of NDEL1 Promotes Growth and Invasion of Glioma Stem-like Cells.
Jiang Y; Song Y; Wang R; Hu T; Zhang D; Wang Z; Tie X; Wang M; Han S
Cancer Res; 2019 May; 79(10):2593-2603. PubMed ID: 30940662
[TBL] [Abstract][Full Text] [Related]
5. New advances of microRNAs in glioma stem cells, with special emphasis on aberrant methylation of microRNAs.
Zhao B; Bian EB; Li J; Li J
J Cell Physiol; 2014 Sep; 229(9):1141-7. PubMed ID: 24374932
[TBL] [Abstract][Full Text] [Related]
6. A novel drug conjugate, NEO212, targeting proneural and mesenchymal subtypes of patient-derived glioma cancer stem cells.
Jhaveri N; Agasse F; Armstrong D; Peng L; Commins D; Wang W; Rosenstein-Sisson R; Vaikari VP; Santiago SV; Santos T; Chen L; Schönthal AH; Chen TC; Hofman FM
Cancer Lett; 2016 Feb; 371(2):240-50. PubMed ID: 26683773
[TBL] [Abstract][Full Text] [Related]
7. Indoleamine 2,3-dioxygenase 1 is highly expressed in glioma stem cells.
Ozawa Y; Yamamuro S; Sano E; Tatsuoka J; Hanashima Y; Yoshimura S; Sumi K; Hara H; Nakayama T; Suzuki Y; Yoshino A
Biochem Biophys Res Commun; 2020 Apr; 524(3):723-729. PubMed ID: 32035622
[TBL] [Abstract][Full Text] [Related]
8. The neurobiology of gliomas: from cell biology to the development of therapeutic approaches.
Westphal M; Lamszus K
Nat Rev Neurosci; 2011 Aug; 12(9):495-508. PubMed ID: 21811295
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of glioma stem cells.
Sampetrean O; Saya H
Brain Tumor Pathol; 2013 Oct; 30(4):209-14. PubMed ID: 23584571
[TBL] [Abstract][Full Text] [Related]
10. Glioma stem cells are more aggressive in recurrent tumors with malignant progression than in the primary tumor, and both can be maintained long-term in vitro.
Huang Q; Zhang QB; Dong J; Wu YY; Shen YT; Zhao YD; Zhu YD; Diao Y; Wang AD; Lan Q
BMC Cancer; 2008 Oct; 8():304. PubMed ID: 18940013
[TBL] [Abstract][Full Text] [Related]
11. Delineating the cytogenomic and epigenomic landscapes of glioma stem cell lines.
Baronchelli S; Bentivegna A; Redaelli S; Riva G; Butta V; Paoletta L; Isimbaldi G; Miozzo M; Tabano S; Daga A; Marubbi D; Cattaneo M; Biunno I; Dalprà L
PLoS One; 2013; 8(2):e57462. PubMed ID: 23468990
[TBL] [Abstract][Full Text] [Related]
12. The PGI-KLF4 pathway regulates self-renewal of glioma stem cells residing in the mesenchymal niches in human gliomas.
Zhu XY; Wang L; Luan SH; Zhang HS; Huang WT; Wang NH
Neoplasma; 2014; 61(4):401-10. PubMed ID: 24645841
[TBL] [Abstract][Full Text] [Related]
13. Imaging glioma initiation in vivo through a polished and reinforced thin-skull cranial window.
Zhang L; Lapierre A; Roy B; Lim M; Zhu J; Wang W; Sampson SB; Yun K; Lyons B; Li Y; Lin DT
J Vis Exp; 2012 Nov; (69):. PubMed ID: 23207870
[TBL] [Abstract][Full Text] [Related]
14. Neural stem cells preferentially migrate to glioma stem cells and reduce their stemness phenotypes.
Zhang S; Xie R; Zhao T; Yang X; Han L; Ye F; Lei T; Wan F
Int J Oncol; 2014 Nov; 45(5):1989-96. PubMed ID: 25176161
[TBL] [Abstract][Full Text] [Related]
15. The cancer stem cell niche(s): the crosstalk between glioma stem cells and their microenvironment.
Filatova A; Acker T; Garvalov BK
Biochim Biophys Acta; 2013 Feb; 1830(2):2496-508. PubMed ID: 23079585
[TBL] [Abstract][Full Text] [Related]
16. Stem cell signature in glioblastoma: therapeutic development for a moving target.
Nakano I
J Neurosurg; 2015 Feb; 122(2):324-30. PubMed ID: 25397368
[TBL] [Abstract][Full Text] [Related]
17. Brain tumor stem cells as therapeutic targets in models of glioma.
Laks DR; Visnyei K; Kornblum HI
Yonsei Med J; 2010 Sep; 51(5):633-40. PubMed ID: 20635435
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of miR-210 decreases hypoxic glioma stem cells stemness and radioresistance.
Yang W; Wei J; Guo T; Shen Y; Liu F
Exp Cell Res; 2014 Aug; 326(1):22-35. PubMed ID: 24930954
[TBL] [Abstract][Full Text] [Related]
19. Aberrant mesenchymal differentiation of glioma stem-like cells: implications for therapeutic targeting.
Balasubramaniyan V; Vaillant B; Wang S; Gumin J; Butalid ME; Sai K; Mukheef F; Kim SH; Boddeke HW; Lang F; Aldape K; Sulman EP; Bhat KP; Colman H
Oncotarget; 2015 Oct; 6(31):31007-17. PubMed ID: 26307681
[TBL] [Abstract][Full Text] [Related]
20. Identification of a Prognostic Hypoxia-Associated Gene Set in IDH-Mutant Glioma.
Dao Trong P; Rösch S; Mairbäurl H; Pusch S; Unterberg A; Herold-Mende C; Warta R
Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30257451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]